research use only

PT2977 (Belzutifan) HIF-2α inhibitor

Name: PT2977 (Belzutifan)
Brand: Selleck Chemicals
SKU: S8886
Availability: InStock
Rating: 5 (2 reviews)

Cat.No.S8886

Belzutifan (PT2977), an orally active and selective HIF-2α inhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC).

Chemical Structure

Molecular Weight: 383.34

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability Specificity

Quality Control

Batch: S888601 DMSO]77 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.79%

99.79

Related Targets	Antioxidant ROS HSP JNK eIF PERK IRE1 PKR ASK PDI ATF-6 ER stress
Related Products	PX-478 Dihydrochloride BAY 87-2243 KC7F2 Lificiguat (YC-1) IOX2 CAY10585 (LW 6) Molidustat (BAY 85-3934) PT2385 IDF-11774 MK-8617 Daprodustat (GSK1278863) FG-2216 Vadadustat Glucosamine Enarodustat (JTZ-951) SYP-5 IOX4 TP0463518 Hydroxy-HIF-1α (Pro564) Antibody [P20E16] AMF Antibody [P19C6] Desidustat CITED2 Antibody [M14P1] ARNT/HIF-1 β Antibody [G7C12] PT2399 Acriflavine HIF-1α Antibody [E5D19] PHD-1-IN-1 HIF-1β/ARNT Antibody [P12A23] Adaptaquin FM19G11

Solubility

In vitro
Batch:

DMSO : 77 mg/mL (200.86 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
Mass value Mass unit	Concentration value Concentration unit	Volume value Volume unit	Molecular weight (g/mol)

Dilution Calculator Molecular Weight Calculator

In vivo batch selection In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	3.850mg/ml (10.04mM)	Taking the 1 mL working solution as an example, add 50 μL of 77 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% Corn oil Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	1.250mg/ml (3.26mM)	Taking the 1 mL working solution as an example, add 50 μL of 25 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg

Average weight of animals: g

Dosing volume per animal: μL

Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO

% Tween 80

% ddH₂O

% DMSO

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight	383.34	Formula	C₁₇H₁₂F₃NO₄S	Storage (From the date of receipt)	3 years -20°C powder
CAS No.	1672668-24-4	--		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent
Synonyms	MK-6482			Smiles	CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O

Mechanism of Action

Targets/IC₅₀/Ki	HIF-2α ^[1] 9 nM
References	[1] https://pubmed.ncbi.nlm.nih.gov/31282155/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04994522	Completed	End Stage Renal Disease\|Renal Impairment	Merck Sharp & Dohme LLC	July 12 2022	Phase 1
NCT04846920	Active not recruiting	Carcinoma Renal Cell	Merck Sharp & Dohme LLC	June 14 2021	Phase 1
NCT04627064	Active not recruiting	Clear Cell Renal Cell Carcinoma	Dana-Farber Cancer Institute\|Eli Lilly and Company	December 31 2020	Phase 1
NCT04489771	Active not recruiting	Carcinoma Renal Cell	Merck Sharp & Dohme LLC	September 13 2020	Phase 2
NCT03634540	Active not recruiting	Renal Cell Carcinoma (RCC)\|Clear Cell Renal Cell Carcinoma (ccRCC)\|Kidney Cancer\|Renal Cancer\|Renal Cell Carcinoma\|Renal Cell Cancer Metastatic\|Renal Cell Carcinoma Recurrent\|Renal Cell Cancer Recurrent\|Kidney	Peloton Therapeutics Inc. a subsidiary of Merck & Co. Inc. (Rahway New Jersey USA)	September 27 2018	Phase 2
NCT03401788	Active not recruiting	VHL - Von Hippel-Lindau Syndrome\|VHL Gene Mutation\|VHL Syndrome\|VHL Gene Inactivation\|VHL-Associated Renal Cell Carcinoma\|VHL-Associated Clear Cell Renal Cell Carcinoma	Peloton Therapeutics Inc. a subsidiary of Merck & Co. Inc. (Rahway New Jersey USA)	May 2 2018	Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):